Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: plain and simple

plain and simple

posted on Oct 23, 2008 01:44PM

I've been in PTSC since before 2000. Bought at 5.00 if I remember correctly, and lost some, bought back again around 2.00 lost some, and then was lucky to catch some shares before the big runup at the beginning of 2006. I have accumulated since and I am happy to sit on what I have with the anticipation of a favorable USPTO ruling on the MMP.

That my friends is the bottom line for me. I whole-heartedly agree with many about wanting to see PTSC expand into other businesses, just as I had hoped for with Ignite, Juice, etc. including MOU in China, etc. And being a data analyst it's fun to read about Crossflo, etc. and the potential.

But it all comes back to the patents. Otherwise PTSC is just another company fighting and scratching their way through a forest for customers, etc.

I voted no on the proposals because I am just plain exhausted with this market, the financial bailout, and news of executive overcompensation. That and the price of our shares at or near a 52-week low does not put me in a good frame of mind to give our CEO and BoD another 100 million shares to give away.

If we have 20+ million in cash, give employees bonuses in cash. Let them buy their own shares at the market price.

We haven't even seen the financials from Crossflo yet we are expected that we have to divvy out options to retain employees. Well, look around folks. I haven't heard of a lot of hiring going on in the tech world right now.

I am happy with Rick Goerner as CEO. He has done a fine job and together he and Don Schrock will lead us to greener pastures. I just disagree with the need and the timing of this dilution.

Come back in another year if you are still here Don, and show us the stock price, and the patents in your back pocket - then we can talk.



Share
New Message
Please login to post a reply